Literature DB >> 29033629

Electroconvulsive Therapy in the Treatment of Mood Disorders: One-Year Follow-up.

Sibel Çakir1, Nuran Çağlar1.   

Abstract

INTRODUCTION: Electroconvulsive therapy (ECT) is known to be an effective option in the treatment of mood disorders, especially resistant depression. However, the remission achieved by ECT was reported to be not long lasting enough. The aim of the present study was to investigate the relapse/recurrence rates and associated risk factors during the first year after ECT in patients diagnosed with mood disorders.
METHODS: In a naturalistic observation, patients diagnosed with unipolar depressive disorder or a depressive episode of bipolar disorder and who had achieved remission by ECT were followed up for at least one year. The patients were evaluated with structured interviews during the follow-up period. The relapse/recurrence rates were the primary outcome measurements, while hospitalization and suicide attempts were the secondary outcome measurements. The remitted and non-remitted patients were compared regarding the clinical features, ECT, and pharmacological variables.
RESULTS: Fifty of 62 patients who had achieved remission with ECT completed the one year follow-up period. Thirty-three patients (66%) had relapse/recurrence, while 17 (34%) patients remained in remission. The relapse rates were similar in patients with unipolar depression and bipolar disorders. The mean number of ECT sessions was higher in relapsed patients with bipolar disorders. Multiple episodes were more frequent in non-remitted patients with unipolar depression. Comorbid psychiatric diagnosis was higher in non-remitted patients with unipolar and bipolar disorders.
CONCLUSION: The relapse/recurrence rate was found to be fairly high in the first year of follow-up in patients who had achieved remission with ECT. ECT decisions should be made carefully in patients with comorbid psychiatric diagnosis and multiple episodes as these are more risky. The ECT application procedure and successive maintenance treatment (maintenance ECT, pharmacotherapy, and psychotherapy) should be planned to sustain the remission for patients with mood disorders in long-term follow-up.

Entities:  

Keywords:  Electroconvulsive therapy; major depression; mood disorders; relapse; remission

Year:  2016        PMID: 29033629      PMCID: PMC5630095          DOI: 10.5152/npa.2016.14845

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  34 in total

1.  A meta-analysis of electroconvulsive therapy efficacy in depression.

Authors:  King Han Kho; Michiel Floris van Vreeswijk; Steve Simpson; Aeilko H Zwinderman
Journal:  J ECT       Date:  2003-09       Impact factor: 3.635

Review 2.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

3.  Declining use of electroconvulsive therapy in United States general hospitals.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Lawrence H Price; Carole E Siegel; Mark Olfson; Steven C Marcus
Journal:  Biol Psychiatry       Date:  2012-10-08       Impact factor: 13.382

4.  Retrospective study of continuation electroconvulsive therapy in 50 patients.

Authors:  Jeroen A van Waarde; Dianne Wielaard; Jaap Wijkstra; Bastiaan Verwey; Rose C van der Mast
Journal:  J ECT       Date:  2010-12       Impact factor: 3.635

5.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

6.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; Serge Beaulieu; Martin Alda; Claire O'Donovan; Glenda Macqueen; Roger S McIntyre; Verinder Sharma; Arun Ravindran; L Trevor Young; Roumen Milev; David J Bond; Benicio N Frey; Benjamin I Goldstein; Beny Lafer; Boris Birmaher; Kyooseob Ha; Willem A Nolen; Michael Berk
Journal:  Bipolar Disord       Date:  2012-12-12       Impact factor: 6.744

7.  Prediction of recurrence in recurrent depression: a 5.5-year prospective study.

Authors:  Mascha C ten Doesschate; Claudi L H Bockting; Maarten W J Koeter; Aart H Schene
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

8.  Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.

Authors:  Pierpaolo Medda; Mauro Mauri; Sara Fratta; Benedetta Ciaponi; Mario Miniati; Cristina Toni; Liliana Dell'Osso; Giulio Perugi
Journal:  J ECT       Date:  2013-09       Impact factor: 3.635

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

Review 10.  Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review.

Authors:  Pascal Sienaert; Lore Lambrichts; Annemiek Dols; Jürgen De Fruyt
Journal:  Bipolar Disord       Date:  2012-11-27       Impact factor: 6.744

View more
  2 in total

Review 1.  Can seizure therapies and noninvasive brain stimulations prevent suicidality? A systematic review.

Authors:  Yiming Chen; Charline Magnin; Jérome Brunelin; Edouard Leaune; Yiru Fang; Emmanuel Poulet
Journal:  Brain Behav       Date:  2021-04-10       Impact factor: 2.708

2.  A Systematic Review of Neuromodulation Treatment Effects on Suicidality.

Authors:  Mehmet Utku Kucuker; Ammar G Almorsy; Ayse Irem Sonmez; Anna N Ligezka; Deniz Doruk Camsari; Charles P Lewis; Paul E Croarkin
Journal:  Front Hum Neurosci       Date:  2021-06-25       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.